Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saakshi Medtech and Panels's EBIT per Share for the
six
months ended in Mar. 2026 was ₹5.06.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5.06.
During the past 12 months, the average EBIT per Share Growth Rate of Saakshi Medtech and Panels was 171.90% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -1.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 12.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Saakshi Medtech and Panels's EBIT per Share or its related term are showing as below:
NSE:SAAKSHI'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -23.1 Med: 10.5 Max: 50.7
Current: -1.4
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Saakshi Medtech and Panels was 50.70% per year. The lowest was -23.10% per year. And the median was 10.50% per year.
NSE:SAAKSHI's 3-Year EBIT Growth Rate is ranked worse than 59.4% of 2505
companies
in the Industrial Products industry
Industry Median: 4.8
vs NSE:SAAKSHI: -1.40
Saakshi Medtech and Panels (NSE:SAAKSHI) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Saakshi Medtech and Panels EBIT per Share Related Terms
Saakshi Medtech and Panels EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹5.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saakshi Medtech and Panels (NSE:SAAKSHI) has a EBIT per Share of ₹5.06 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Saakshi Medtech and Panels and its competitors. According to the industry distribution chart, Saakshi Medtech and Panels ranks #1488 out of 2505 companies in the Industrial Products industry, placing it in the top 59.4%.
Is Saakshi Medtech and Panels' EBIT per Share too high?
Saakshi Medtech and Panels' current EBIT per Share is ₹5.06. Based on the distribution chart, Saakshi Medtech and Panels ranks #1488 out of 2505 companies in the Industrial Products industry, which is below the industry midpoint. Overall, Saakshi Medtech and Panels has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Saakshi Medtech and Panels' EBIT per Share compare to VRT and BE?
According to the Industrial Products industry distribution chart, Saakshi Medtech and Panels ranks #1488 out of 2505 companies for EBIT per Share. This places Saakshi Medtech and Panels in the lower half of its industry. The industry median EBIT per Share is 4.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for an Industrial Products company?
The median EBIT per Share among Industrial Products companies is 4.80, based on 2,505 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Saakshi Medtech and Panels and its competitors. For the Industrial Products industry, the median EBIT per Share is 4.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saakshi Medtech and Panels's current EBIT per Share is ₹5.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saakshi Medtech and Panels stock overvalued right now?
Based on GuruFocus' analysis, Saakshi Medtech and Panels (NSE:SAAKSHI) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹220.57, compared to a current price of ₹345.40 — trading 56.6% above its estimated fair value. The current EBIT per Share is ₹5.06. Saakshi Medtech and Panels' overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Saakshi Medtech and Panels (NSE:SAAKSHI), the current EBIT per Share is ₹5.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saakshi Medtech and Panels (NSE:SAAKSHI) Overvalued in 2026?
Based on GuruFocus' analysis, Saakshi Medtech and Panels stock appears to be overvalued.
The current stock price of ₹345.40 is trading 56.6% above its estimated GF Value™ of ₹220.57.
GuruFocus considers Saakshi Medtech and Panels to be Significantly Overvalued.
Key valuation signals for NSE:SAAKSHI:
EBIT per Share: ₹5.06
GF Value™: ₹220.57 vs. price of ₹345.40 (56.6% above fair value)
No single metric tells the full story. See the NSE:SAAKSHI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saakshi Medtech and Panels Ltd is a diversified company engaged in manufacturing Electrical Control Panels and Cabinets used in elevators, air compressors, renewable energy industry, oil & gas exploration industry, electrical vehicle charging stations, medical X-Ray Systems used in healthcare industry, fabrication works for locomotives, and wire harness division for their captive consumption in electrical control panels and for supply to air compressor industry. Their comprehensive solutions include design, process engineering, and manufacturing including fabrication, assembly, and testing facilities. It designs, programs, and assembles Electrical Control Panels and Cabinets comprising microcontrollers, programmable logic controllers, and SCADA systems.
50GF Score
Get the complete analysis for NSE:SAAKSHI
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAAKSHI has been successfully added to your 
